147 related articles for article (PubMed ID: 35229640)
1. VPS29 Exerts Opposing Effects on Endocytic Viral Entry.
Poston D; Weisblum Y; Hobbs A; Bieniasz PD
mBio; 2022 Apr; 13(2):e0300221. PubMed ID: 35229640
[TBL] [Abstract][Full Text] [Related]
2. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
3. Many Keys Unlock the Doors for Virus Entry.
Gallagher T
mBio; 2022 Jun; 13(3):e0044522. PubMed ID: 35579391
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenaviruses Using Late Endocytic Trafficking to Enter Cells.
Stewart CM; Bo Y; Fu K; Chan M; Kozak R; Apperley KY; Laroche G; Daniel R; Beauchemin AM; Kobinger G; Kobasa D; Côté M
ACS Infect Dis; 2023 May; 9(5):1064-1077. PubMed ID: 37053583
[TBL] [Abstract][Full Text] [Related]
5. Glucosylceramidase Maintains Influenza Virus Infection by Regulating Endocytosis.
Drews K; Calgi MP; Harrison WC; Drews CM; Costa-Pinheiro P; Shaw JJP; Jobe KA; Nelson EA; Han JD; Fox T; White JM; Kester M
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918081
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.
Keshavarz Valian N; Pourakbari B; Asna Ashari K; Hosseinpour Sadeghi R; Mahmoudi S
J Med Virol; 2022 Apr; 94(4):1450-1456. PubMed ID: 34786736
[TBL] [Abstract][Full Text] [Related]
7. Prolidase is required for early trafficking events during influenza A virus entry.
Pohl MO; Edinger TO; Stertz S
J Virol; 2014 Oct; 88(19):11271-83. PubMed ID: 25031340
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus 16 Infection Induces VAP-Dependent Endosomal Tubulation.
Siddiqa A; Massimi P; Pim D; Broniarczyk J; Banks L
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321327
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
10. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.
Yang B; Jia Y; Meng Y; Xue Y; Liu K; Li Y; Liu S; Li X; Cui K; Shang L; Cheng T; Zhang Z; Hou Y; Yang X; Yan H; Duan L; Tong Z; Wu C; Liu Z; Gao S; Zhuo S; Huang W; Gao GF; Qi J; Shang G
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35022217
[TBL] [Abstract][Full Text] [Related]
11. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
[TBL] [Abstract][Full Text] [Related]
12. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
[TBL] [Abstract][Full Text] [Related]
13. An overview on the seven pathogenic human coronaviruses.
Kesheh MM; Hosseini P; Soltani S; Zandi M
Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
[TBL] [Abstract][Full Text] [Related]
14. Robust Evaluation of Ultraviolet-C Sensitivity for SARS-CoV-2 and Surrogate Coronaviruses.
Boegel SJ; Gabriel M; Sasges M; Petri B; D'Agostino MR; Zhang A; Ang JC; Miller MS; Meunier SM; Aucoin MG
Microbiol Spectr; 2021 Oct; 9(2):e0053721. PubMed ID: 34668746
[TBL] [Abstract][Full Text] [Related]
15. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
[TBL] [Abstract][Full Text] [Related]
16. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
17. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
[TBL] [Abstract][Full Text] [Related]
18. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
Shirato K; Kanou K; Kawase M; Matsuyama S
J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
[TBL] [Abstract][Full Text] [Related]
19. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.
Obajuluwa AO; Okiki PA; Obajuluwa TM; Afolabi OB
Pan Afr Med J; 2020; 37():285. PubMed ID: 33654512
[TBL] [Abstract][Full Text] [Related]
20. Mucolipin-2 Cation Channel Increases Trafficking Efficiency of Endocytosed Viruses.
Rinkenberger N; Schoggins JW
mBio; 2018 Jan; 9(1):. PubMed ID: 29382735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
